statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VERV The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc.

VERV The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc. VERV The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc. PR...

VERV Investors Have the Opportunity to Join Investigation of Verve Therapeutics, Inc. with the Schall Law Firm

VERV Investors Have the Opportunity to Join Investigation of Verve Therapeutics, Inc. with the Schall Law Firm VERV Investors Have the Opportunity to Join Investigation of Verve Therapeutics, Inc...

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws Wolf Haldenstein Adler Freeman & Herz LLP...

Insider Selling: Verve Therapeutics, Inc. (NASDAQ:VERV) Insider Sells 1,514 Shares of Stock

Verve Therapeutics, Inc. (NASDAQ:VERV - Get Free Report) insider Joan Nickerson sold 1,514 shares of Verve Therapeutics stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold...

Verve Therapeutics price target lowered by $16 at Stifel, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Verve Therapeutics Stock Remains A Hold After VERVE-101 Enrollment Pause

Verve Therapeutics Stock Remains A Hold After VERVE-101 Enrollment Pause...

Verve Therapeutics Announces Updates on its PCSK9 Program

Heart-1 clinical trial demonstrated LDL-C reduction of up to 73% at 0.45 mg/kg of VERVE-101 Company to pause enrollment in Heart-1 clinical trial following asymptomatic Grade 3 transient ALT...

Attention Verve Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Verve Therapeutics, Inc...

Verve Therapeutics (VERV, $12.79) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that VERV's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve...

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Volume	857,799.00
52-Wk High	$20.58
52-Wk Low	$4.59

VERV Verve Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals